massachusetts health official loss explain pharmacy linked outbreak able operate despite concernsthe top public health official massachusetts admitted troubling question remain regulator failed eight year ago severely sanction pharmacy linked fatal fungal meningitis outbreak killed 32 people across september 2004 product safety sterility problem new england compounding center included meningitis symptom two patient linked methylprednisolone injectable steroid implicated current outbreak state pharmacy board recommended official reprimand three year probation additional sterility training brian cadden firm owner the company protested saying would destroy business testimony delivered congressional inquiry wednesday dr lauren smith said despite interview state pharmacy board review limited record surrounding safety problem necc 2002 3 unable determine influenced lenient consent agreement resolution given necc track record instead board responsible oversight compounding pharmacy entered significantly weaker consent agreement necc 2006 smith appointed public health department interim commissioner three week ago added satisfied know full story behind decision concluded company linked deadly meningitis outbreak began september bear primary responsibility health scandal said necc knowingly disregarded sterility test prepared medicine unsanitary condition unlawfully engaged manufacturing endangering thousand life result necc bear primary responsibility harm caused action however smith testimony house energy commerce committee raise question answer despite repeated complaint problem investigation company license revoked sanction imposed memo committee oversight investigation subcommittee state far back 2003 food drug administration warned potential serious public health consequence necc compounding practice particular relating sterile product improved memo released monday show several year problem fda official 2003 suggested compounding pharmacy prohibited manufacturing improved operation but fda regulator deferred counterpart massachusetts ultimately reached agreement pharmacy settle concern quality prescription injection health scandal raised number question monitoring regulation compounding pharmacy memo published website subcommittee noted fda said long pharmacy operation fall within scope practice pharmacy fda continue defer state authority regulatory oversight hearing wednesday investigate whether outbreak could prevented legislator ask fda commissioner margaret hamburg agency pursue enforcement action massachusetts official allowed necc keep license fred upton republican chairman committee also sent subpoena cadden refused give evidence statement committee said committee long bipartisan history conducting drug safety oversight since meningitis outbreak close contact involved agency party many unanswered question remain the necc history problem documented fda warning letter 2006 we want know went wrong facility view action regulator step taken ensure outbreak never happens committee first hear joyce lovelace whose husband eric kentucky judge died stroke linked meningitis outbreak 17 september he first person die result contaminated steroid linked necc autopsy earlier month confirmed death connected tainted steroid shot received week earlier tennessee treat neck back pain senate health committee plan hearing thursday memorandum committee oversight investigation subcommittee listed many reported incident concerning similar identical underlying misconduct necc violations observed regulator early 2002 include company failure maintain adequate standard sterile injectable product issue center current meningitis outbreak said since company formation 1998 food drug administration conducted three inspection based separate set allegation event the massachusetts board pharmacy main regulatory body charge necc investigated least 12 separate complaint concerning necc cadden issued least four advisory letter monday fda released 20 page report listed string unsafe practice unsanitary condition ameridose sister drug company necc also owned cadden described result month long inspection last month there rusty unclean equipment penetrating leak cracked wall covered appeared adhesive glove gown sterile insect 10 foot away sterile product packaged stored at least one bird found flying around area said inspector also said ameridose failed adequately investigate complaint serious reaction patient might flagged drug potency problem the firm failed appropriately classify patient response complaint adverse event said complaint relation one drug oxytocin included fetal distress hyperstimulated uterus five case maternal haemorrhaging shortness breath throat closing report said problem cited another drug heptarin included life threatening adverse effect patient problem fentanyl included patient sedated unresponsive another two patient went respiratory distress receiving medication